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Summary
 
CD4/CD8 lineage decision is an important event during T cell maturation in the thymus.
CD8 T cell differentiation usually requires corecognition of major histocompatibility complex
(MHC) class I by the T cell receptor (TCR) and CD8, whereas CD4 T cells differentiate as a
consequence of MHC class II recognition by the TCR and CD4. The involvement of specific
peptides in the selection of T cells expressing a particular TCR could be demonstrated so far
for the CD8 lineage only. We used mice transgenic for an MHC class II-restricted TCR to in-
vestigate the role of antagonistic peptides in CD4 T cell differentiation. Interestingly, antago-
nists blocked the development of CD4
 
1
 
 cells that normally differentiate in thymus organ cul-
ture from those mice, and they induced the generation of CD8
 
1
 
 cells in thymus organ culture
from mice impaired in CD4
 
1
 
 cell development (invariant chain–deficient mice). These results
are in line with recent observations that antagonistic signals direct differentiation into the CD8
lineage, regardless of MHC specificity.
Key words: antagonist • major histocompatibility complex • thymocyte differentiation • 
thymic selection • T cell receptor
he T cell repertoire is shaped in the thymus by posi-
tive and negative selection, such that the mature T
cell population recognizes foreign antigens and tolerates
self-peptides. The involvement of self-peptide in both se-
lection processes has been explained by the avidity model,
according to which high avidity interactions between thy-
mocytes and antigen presenting cells lead to deletion of T
cells, whereas low avidity interactions induce positive se-
lection (for reviews see references 1, 2).
The selection of CD8
 
1
 
 cells expressing MHC class
I-restricted TCRs appears to follow this model. Positive se-
lection of T cells expressing a class I-restricted transgenic
TCR was induced in fetal thymic organ culture with low
concentrations of antigenic peptide, whereas high concen-
trations of the same peptide induced negative selection (3,
4). More efficiently, analogues of the antigenic peptide
could be used for the induction of positive selection (4, 5).
Such analogues are frequently antagonists of mature T cells
and were shown to provide a decreased affinity interaction
with the TCR (6). The fact that analogues of the antigenic
peptide, but rarely unrelated peptides (7–9), caused positive
selection of CD8
 
1
 
 cells indicated a high degree of peptide
specificity for selection whenever single peptides were
used.
Surprisingly, nobody has reported positive selection of
transgenic class II-restricted cells using similar assays. On
the other hand, mice expressing class II molecules loaded
with a single peptide were used to identify T cells selected
by this single ligand. In H2-M-deficient mice that almost
exclusively display class II-associated invariant chain pep-
tides on their class II molecules (10–12), as well as in mice
expressing an E
 
a
 
 peptide in the context with H2-A
 
b
 
 in the
absence of endogenous class II molecules (13), a diverse
repertoire was selected, although with less efficiency than
in wild-type mice. This indicated a less stringent peptide
specificity for positive selection of class II-restricted TCRs.
Also, introduction of single peptides into mice by means of
intrathymic injection of an adenovirus vector expressing
such peptides provided evidence that in addition to anti-
genic peptide and its analogues, some unrelated peptides
could induce positive selection (14).
A disadvantage of these polyclonal, nontransgenic sys-
tems is that they do not give information about particular
TCR V
 
a
 
V
 
b
 
 
 
sequences selected. The fact that none of sev-
eral different transgenic TCRs was positively selected in
H2-M-deficient and E
 
a
 
/H2-A
 
b
 
 expressing mice (15–17)
shows that unrelated single peptides are less adequate for
positive selection than one might conclude from a poly-
 
T
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clonal repertoire. The only report in which a transgenic
class II-restricted TCR system with known TCR V
 
a
 
V
 
b
 
sequences was used to investigate positive selection medi-
ated by antigen-related peptides was by Spain et al. (18).
They showed that the addition of antagonist peptide to
fetal thymic organ culture of class II-restricted thymocytes
inhibits the development of CD4
 
1
 
 cells. However, this
study was performed on a normally selecting background
in which endogenous peptides are presented. Therefore,
the inhibition of CD4
 
1
 
 cell development might have been
due to interference of the antagonist peptide with the phys-
iological positively selecting peptide.
To circumvent this potential problem, we used invariant
chain deficient mice (Ii
 
2
 
/
 
2
 
) that express reduced levels of
surface MHC class II molecules with greatly increased abil-
ity to present exogenously added class II binding peptides
(19, 20). These mice were crossed to the MHC class II-
restricted TCR transgenic mouse line A18 to enable analy-
ses of selection requirements for a particular TCR. This
TCR is specific for a peptide derived from the fifth com-
ponent of complement (21). Neonatal thymic lobes
(NTOC)
 
1
 
 from these mice did not generate mature CD4
 
1
 
cells, due to an altered repertoire of self-peptides bound to
class II that is lacking the endogenous peptide responsible
for positive selection. When antagonist peptide was loaded
exogenously onto class II molecules, CD4
 
1
 
 cell develop-
ment could not be rescued. Instead, this treatment resulted
in the generation of CD8
 
1
 
 cells. These data address impor-
tant questions about the interaction of the TCR and its
ligand, leading to CD4 versus CD8 lineage commitment.
 
Materials and Methods
 
Mice.
 
The C5 TCR transgenic mouse line A18 on the
Rag1
 
2
 
/
 
2
 
 background (21) was crossed to invariant chain deficient
mice (20) to generate Rag
 
2
 
/
 
2
 
, Inv
 
2
 
/
 
2
 
 A18 transgenic mice.
Genotyping was performed by PCR analysis.
 
Peptides. 
 
The agonist peptide for the A18 T cell receptor is
peptide 106–121 from mouse C5. Two antagonists were gener-
ated by replacement of lysine residue 113 with either isoleucine
for antagonist 113I (K 
 
® 
 
I) or with valin for antagonist 113V
(K 
 
® 
 
V). Antagonist 113V was used for the organ cultures.
 
Antagonist Assay. 
 
Dendritic cells derived from cultures of
bone marrow cells with GM-CSF as described (22) were pulsed
with 10 nM A18 agonist peptide for 2 h. They were then washed
and cultured with different doses of antagonist or control peptide
in the presence of spleen T cells from A18 Rag1
 
2
 
/
 
2
 
 
 
TCR trans-
genic mice. After 48 h of culture, supernatants were transferred to
fresh wells with 5,000/well IL-2–dependent CTLL cells and pro-
liferation of CTLL was assessed by uptake of [
 
3
 
H]thymidine.
 
Thymus Organ Culture. 
 
NTOC were cut in half and placed
on nucleopore membranes (0.8 
 
m
 
m pore size; Costar Corp.,
Cambridge, MA) floating on 1 ml Iscove’s modified Dulbecco’s
medium (Life Technologies, Inc., Paisley, Scotland) supplemented
with 10% heat-inactivated FCS, 5 
 
3 
 
10
 
2
 
5
 
 M 2-mercaptoethanol,
2 
 
3 
 
10
 
2
 
3
 
 M L-glutamine, 100 U/ml penicillin, 100 
 
m
 
g/ml strep-
tomycin, and peptide when indicated. Medium containing pep-
tides was changed daily. After 7 d of organ culture, thymic lobes
were mechanically disaggregated into single cell suspensions.
 
FACS
 
Ò
 
 Analyses and Antibodies.
 
Expression of cell surface an-
tigens by thymocytes from NTOC was determined by cytofluo-
rometry using a FACScan
 
Ò
 
 and Cell Quest software (Becton
Dickinson & Co., Mountain View, CA). Dead cells were ex-
cluded by forward and side scatter characteristics. mAbs used
were PE-labeled anti–CD4 (H129.19; Boehringer Mannheim,
Mannheim, Germany), FITC-labeled anti–CD8
 
a
 
 (YTS 169.4;
reference 23), biotinylated anti–CD8
 
b
 
 (KT112, provided by K.
Tomonari, Fukui Medical School, Fukui, Japan), biotinylated
anti–heat-stable antigen (HSA) (YBM 5.10; reference 24), or bi-
otinylated anti–V
 
b
 
8.3 (25). Biotinylated mAb were detected with
streptavidin-Red670 (GIBCO BRL, Gaithersburg, MD).
 
Functional Analyses. 
 
Thymocytes from NTOC were plated
out in 96-well microtiter plates (5 
 
3 
 
10
 
4
 
/well) and treated with 10
 
m
 
g/ml anti–CD4 (RL172.4), 10 
 
m
 
g/ml anti–CD8
 
a
 
 (3.168), or no
mAbs, before adding rabbit complement (Cedarlane Labs. Ltd.,
Hornby, Ontario, Canada) for 45 min at 37
 
8
 
C. Cells were washed
three times, and then cultured with bone marrow dendritic cells
(2 
 
3 
 
10
 
4
 
/well) in the presence of 1 
 
m
 
M C5 peptide 106–121 for
72 h. Supernatant was tested for the presence of IL-2 by its ability
to support growth of IL-2–dependent CTLL indicator cells.
 
Results
 
Identification of Peptide Antagonists for the Transgenic TCR
A18. 
 
Exchange of lysine residue 113 in the C5 peptide
recognized by the A18 TCR results in loss of stimulatory
activity for C5-specific A18 T cells. Two such altered pep-
tides with a change of K
 
 ® 
 
I (peptide 113I) or K
 
 ® 
 
V
(peptide 113V) displayed antagonist activity as judged by
their ability to inhibit activation of A18 T cells to the ago-
nist A18 peptide. Both peptides are nonstimulatory for A18
T cells in a range of concentrations from 1 nM to 10 
 
m
 
M
 
1
 
Abbreviations used in this paper:
 
 HSA, heat-stable antigen; NTOC, neona-
tal thymic lobes.
Figure 1. Peptides 113I and 113V antagonize the activation of A18 T
cells. IL-2 response of A18 TCR transgenic spleen cells in response to
dendritic cells prepulsed with 10 nM A18 agonist peptide, and then cul-
tured in the presence of peptide 113I (j), peptide 113V (r), and HEL
peptide 1–18 (d) at indicated concentrations. The figure shows counts
per minute of [3H]thymidine incorporated into CTLL cells. 
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(data not shown). Fig. 1 shows that both 113I and 113V
blocked the IL-2 response of A18 T cells to dendritic cells
prepulsed with agonist peptide, whereas an unrelated H2-
E
 
k
 
 binding peptide from hen egg lysozyme (HEL 1-18,
2G7; reference 26) did not influence the response.
 
TCR Antagonists Efficiently Induce the Differentiation of
CD8
 
1
 
 Cells in Thymus Organ Culture from A18, Invariant
Chain–deficient Mice. 
 
To decrease presentation of endog-
enous peptides and enable preferential loading of exoge-
nously added peptides onto MHC class II molecules, we
crossed class II-restricted TCR-transgenic A18 mice on the
RAG-1
 
2
 
/
 
2
 
 background to invariant chain–deficient (Ii
 
2
 
/
 
2
 
)
mice. MHC class II expression in Ii
 
2
 
/
 
2
 
 mice has been re-
ported to be reduced but not abolished and the absence of
invariant chain interferes with CD4 T cell development of
many, but not all, specificities (20, 27). Neonatal thymus
organ culture of A18 Ii
 
2
 
/
 
2
 
 mice showed no differentiation
of mature CD4
 
1
 
 cells (Fig. 2 
 
A, medium
 
), placing A18 in
the former category. The few CD4
 
1
 
 cells that were found
in NTOC displayed an immature phenotype (TCR
 
lo-int
 
and HSA
 
hi
 
). Thymus cortical epithelial cells, which are re-
sponsible for the induction of positive selection of T cells
(28), show a twofold reduction in MHC class II levels (data
not shown). Since we know that the A18 TCR is posi-
tively selected in F1 mice with the nonselecting H2-
 
q
 
background (Barthlott,T., R.J. Wright, and B. Stockinger,
manuscript submitted for publication), we can exclude that
this degree of reduction in MHC class II expression is the
reason for the lack of mature CD4
 
1
 
HSA
 
lo
 
 cells in A18 Ii
 
2
 
/
 
2
 
lobes. An alternative and more likely explanation for the
defect in positive selection of A18 cells is an impairment in
the processing of the normally positively selecting peptide
or its proper assembly with class II, due to the absence of Ii.
The greatly increased peptide binding capacity of Ii
 
2
 
/
 
2
 
 an-
tigen-presenting cells allowed us to test the effect of exoge-
nously added peptides on positive selection of A18 T cells.
Antagonist peptides have been shown to be successful
in generating class I-restricted CD8 T cells. We asked
whether modified A18 peptides with antagonist activity
for the nominal C5 peptide would rescue the develop-
ment of CD4 T cells in NTOC of invariant chain nega-
tive A18 thymocytes. However, thymus organ culture in
the presence of antagonist peptide did not result in the
generation of mature CD4
 
1
 
 cells at any concentration
tested. Fig. 2 shows antagonist peptide 113V as an exam-
ple, antagonist 113I behaved in the same way (data not
shown). Instead of expected CD4
 
1
 
 cells, CD8
 
1
 
 cells with
the characteristics of mature T cells (TCR
 
hi
 
 HSA
 
lo
 
) were
generated (Fig. 2 
 
A
 
, 
 
1 
 
m
 
M antagonist
 
 and 
 
10 
 
m
 
M antago-
nist
 
). These cells express CD8
 
ab
 
 heterodimers on the sur-
face (Fig. 3). The increased percentage of CD8
 
1
 
 cells was
reproducibly reflected in a 5–10-fold increase in absolute
Figure 2. Generation of MHC class II-restricted CD81 cells in NTOC in the presence of antagonist peptide. Thymocytes from A18 Rag-12/2 new-
borns on the Ii2/2 background (A) or Ii1/2 background (B) were analyzed for their expression of CD4, CD8, TCR, and HSA 7 d after organ culture in
the absence of peptide (medium) or in the presence of 1 or 10 mM antagonist peptide 113V. Percentages of CD4 and CD8 single positive cells are given
in each dot plot. Expression of Vb8.3 and HSA is shown on gated CD4 single positive cells and gated CD8 single positives, as indicated. Gray-filled
curves in each histogram represent expression on thymocytes from NTOC in medium alone for comparison.1086 Antagonist Peptide Selects into the CD8 Lineage
cell numbers as shown in Fig. 4. These CD81 cells could
not have been derived by endogenous receptor rearrange-
ments leading to expression of a class I-restricted TCR
because of the absence of RAG-1 protein in those mice.
Therefore, it clearly demonstrated that the antagonist
peptide caused T cells with the class II-restricted A18
TCR to differentiate into the CD8 lineage. The antago-
nist peptide is presented on MHC class II since anti–class
II antibodies block the generation of CD8 cells in NTOC
(Fig. 3). The antigenic C5 peptide was also tested for its
influence on positive selection in NTOC. However, it
mostly led to deletion of A18 thymocytes. Very ineffi-
cient selection of CD8 and CD4 cells occurred in some
but not all experiments with C5 peptide at picomolar
concentrations (data not shown).
Peptide Antagonists Inhibit the Generation of CD41 Cells in
Thymus Organ Culture from A18 Transgenic Mice.  Thymus
lobes from newborn A18 Ii1/2 mice were cultured under
the same conditions as described above for A18 Ii2/2 lobes,
to test whether the antagonist would influence normal posi-
tive selection. As expected, mature CD41 TCRhi HSAlo
cells, but no mature (HSAlo) CD81 cells were generated
from lobes cultured in medium alone (Fig. 2 B, medium). In
contrast, CD41 cell maturation did not take place in the
presence of antagonist peptide and, as seen with Ii2/2 lobes,
CD81 cell maturation was induced (Fig. 2 B, 1 mM antago-
nist and 10 mM antagonist). Prevention of CD4 lineage com-
mitment by antagonist peptide confirms data from Spain et
al. (18) showing a block in the differentiation of CD41 2B4
TCR transgenic thymocytes in thymus organ culture in the
presence of a cytochrome c antagonist variant. Spain et al.
(18) did not report an enhanced differentiation into the CD8
lineage, presumably because their mice were not deficient
for RAG and therefore contained significant numbers of
CD81 cells in the absence of antagonist peptide.
CD81 Cells Derived in the Presence of Antagonist Are Func-
tionally Mature.  The CD81 cells generated with antago-
nist peptide in NTOC from A18 Ii2/2 mice displayed a
mature phenotype according to their high expression of the
TCR and downregulation of expression as shown in Fig. 2.
To investigate the functional ability of these cells, we cul-
tured them with dendritic cells presenting the C5 agonist
peptide and assayed for IL-2 production. As expected,
given that they contained no mature single positive cells,
thymocytes recovered from NTOC from A18 Ii2/2 mice
did not react to C5 peptide (Fig. 5, medium). In contrast,
lobes cultured in the presence of antagonist peptide gave
rise to thymocytes responding to C5 peptide (Fig. 5, 1 mM
antagonist and 10 mM antagonist). This response was medi-
ated by the CD81 population, as depletion of CD81 cells
before the functional assay ablated C5 reactivity. In con-
trast, depletion of CD41 cells did not affect C5 reactivity.
These results confirm the maturity of the CD81 cells and
also their TCR specificity for C5 peptide. C5 peptide/class
II complex recognition by the A18 TCR in the absence of
CD4 was observed previously in CD4-negative T cell hy-
brids (data not shown).
Discussion
We have demonstrated that antagonist peptide can alter
lineage decision from CD41 to CD81 cells. Previously,
Figure 3. Thymuses from A18 Rag12/2 newborns on the Ii2/2 back-
ground were cultured with 10 mM antagonist peptide 113V in the pres-
ence of 50 mg/ml anti–class II antibody 14.4.4 (right) or mouse IgG as
control (left). Percentages of CD4 and CD8a are given in each dot plot.
The histogram below shows expression of CD8b on cells gated for CD8a
expression to illustrate coexpression of both CD8 chains.
Figure 4. Increased absolute numbers of CD8 single positive cells after
NTOC in the presence of antagonist peptide. Thymic lobes from A18
Rag-12/2 Ii2/2 newborn mice were cultured in medium alone or in me-
dium containing 1 or 10 mM antagonist peptide 113V for 7 d. Thy-
mocytes were counted, stained for the expression of CD4 and CD8, and
analyzed by flow cytometry. Absolute numbers of CD8 single positive
cells per lobe of five lobes from four independent experiments are shown.1087 Volkmann et al.
positive selection of CD81 cells was achieved with peptide
analogues of the antigenic peptide or low concentrations of
the nominal antigen presented by the selecting MHC class I
molecule (3–5). In contrast, positive selection of CD41 cells
could be induced through coengagement of the TCR/CD3
complex with a variety of thymocyte surface molecules such
as CD2, CD4, CD5, CD8, CD24, CD28, CD49d, CD81,
or TSA-1 (29–33). In addition, cross-linking of TCRb or
CD3ge with mAb (34), as well as targeting thymocytes to
thymic cortical epithelium via anti–TCR/CDR-1 hybrid
antibodies (31), resulted in the exclusive generation of CD41
cells even in the absence of MHC molecules. Thus, the sig-
nals for CD4 differentiation seemed to be promiscuous in
comparison to signals for CD8 differentiation and it was sug-
gested that development into the CD4 lineage follows a
“default” pathway (32). However, we show here that CD81
rather than CD41 cells developed, even without the involve-
ment of either CD8 or class I-specific signals. Instead of a
default model for either lineage, the involvement of distinct
signals seems to be more likely.
In terms of the effect of antagonist peptides, it has been
shown that binding of the TCR to MHC molecules occu-
pied by antagonist peptide results in a higher off rate (35,
36). A shorter interaction time between the TCR and its
ligand might not allow sufficient time for coreceptor bind-
ing and consequently for the recruitment of the tyrosine
kinase p56lck (37). Lack of lck recruitment is presumably
more debilitating for CD4 lineage cells since a much larger
fraction of CD4 than CD8 molecules is associated with lck
(38, 39), implying a more prominent role for lck in CD41
cell development. Therefore, the generation of class II-
restricted CD81 cells in NTOC might be the consequence
of insufficient lck recruitment in the presence of antagonist
peptide (40). In support of this, class II-restricted T cells
choose the CD8 pathway in mice lacking the CD4 mole-
cule (41). Recruitment of lck to the TCR complex was
first implied as a major player in CD4 lineage decision by
Itano et al. (42). By introducing a hybrid protein consisting
of the extracellular and transmembrane domain of CD8
and the cytoplasmic part of CD4, they could generate a
large number of MHC class I-restricted CD41 T cells in
transgenic mice. The only known difference to CD8 trans-
genic mice was more efficient lck recruitment by the CD4
cytoplasmic domain. Basson et al. (43) directed differentia-
tion into the CD8 lineage through TCR engagement in-
dependently of MHC specificity by using CD3e-specific
F(ab9)2 antibodies. The CD3-F(ab9)2 reagent was unable to
activate mature T cells and instead resembled an antagonist
peptide in terms of downstream signaling and inhibitory ef-
fect on agonist peptide responses. Based on this, they hy-
pothesized that CD8 cell development is favored by antag-
onist-like signals, which have limited participation of lck
signals. On the other hand, CD4 differentiation would re-
quire a stronger lck signal in relation to the TCR signal.
Our results are consistent with these models and demon-
strate for the first time the ability of a single peptide to con-
vert CD4/CD8 lineage decision.
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Figure 5. CD81 cells recovered from NTOC cul-
tured in the presence of antagonist peptide are func-
tionally mature. Thymocytes were recovered from A18
Rag-12/2 Ii2/2 neonatal thymic lobes after 7 d culture
in medium alone or in medium containing different
concentrations of antagonist peptide 113V as indicated.
Total thymocytes (s), thymocytes depleted of CD41
cells (j), or thymocytes depleted of CD81 cells (m)
were cocultured with dendritic cells in the presence of
1 mM C5 peptide and the supernatants were assayed in
serial dilutions for their content of IL-2. The figure
shows the mean counts per minute (of duplicate exper-
iments) of incorporated [3H]thymidine by CTLL cells.
Cultures without C5 peptide did not contain IL-2 (not
shown).1088 Antagonist Peptide Selects into the CD8 Lineage
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